2 protocol(s) meet the specified criteria
Drug: Alvocidib
Protocol No.TitleStatus
TPI-ALV-102TPI-ALV-102: A Phase 1b/2, Open-label Clinical Study to Determine Preliminary Safety and Efficacy of Alvocidib When Administered in Sequence After Decitabine in Patients with MDSOpen
TPI-ALV-201A Phase 2, Randomized, Biomarker-driven, Clinical Study in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)Open